A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)

  • Glaspole, Ian (Primary Chief Investigator (PCI))
  • Symons, Karen M. (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date7/06/19 → 1/06/22

Keywords

  • respiratory medicine
  • Idiopathic pulmonary fibrosis
  • Clinical trial